Latest News

Apr 13, 2021
Lytix Biopharma decides to initiate a process of raising capital
Mar 29, 2021
Lytix Biopharma enters into an exclusive license agreement with the Arctic University of Norway for a class of new drug candidates - and forms a strategic partnership with the US-based Aurelius Biotherapeutics
Mar 1, 2021
Lytix Biopharma has appointed Gry Stensrud as Chief Technology Officer
Feb 27, 2021
CEO in Lytix Biopharma gives oral presentation at ESMO targeted anticancer therapies virtual congress 2021